Zimmer Biomet completed the first procedures using its ROSA knee robot for total knee replacement. These first five cases were all performed in a single surgery day, by one physician. As we noted in our recap of ZBH’s 3Q18 earnings call, these first cases perhaps hint at the company’s positioning of ROSA as efficient and minimally disruptive to procedure flow.
ZBH acquired the ROSA Robotics portfolio, which includes knee, spine and brain applications, as part of its 2016 acquisition of Medtech.
ROSA is expected to receive FDA 510(k) clearance in 1H19.
Sources: Zimmer Biomet; ORTHOWORLD, Inc.